Publication | Closed Access

Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)

Drug HypersensitivityAutoimmune DiseaseAllergyAtopic DermatitisAllergy MedicineEarly IndicationMedicineImmunologySkin AllergyAutoimmunityDrug-induced Hypersensitivity SyndromeDermatologyDermatopathologyImmunotherapyDrug AllergyDisease ActivityHypersensitivity